Literature DB >> 25873061

Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update.

Gary H Lyman1, Kari Bohlke1, Anna Falanga1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25873061     DOI： 10.1200/JOP.2015.004473

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  44 in total

Review 1.  Supportive care in pancreatic ductal adenocarcinoma.

Authors:  B Laquente; A Calsina-Berna; A Carmona-Bayonas; P Jiménez-Fonseca; I Peiró; A Carrato
Journal:  Clin Transl Oncol       Date:  2017-06-13       Impact factor: 3.405

2.  Four cases of Trousseau syndrome associated with breast cancer that exhibited central nervous system manifestations.

Authors:  Mai Okazaki; Hiroko Bando; Emika Ichioka; Akiko Iguchi-Manaka; Katsuhiro Nasu; Hisato Hara
Journal:  Int Cancer Conf J       Date:  2020-04-04

3.  Extended pharmacologic thromboprophylaxis in oncologic liver surgery is safe and effective.

Authors:  B J Kim; R W Day; C H Davis; N Narula; M H Kroll; C W D Tzeng; T A Aloia
Journal:  J Thromb Haemost       Date:  2017-09-27       Impact factor: 5.824

Review 4.  Prevention and Treatment of Cancer-Associated Venous Thromboembolism: a Review.

Authors:  Kristen M Sanfilippo; Tzu-Fei Wang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-11-20

Review 5.  Direct oral anticoagulants: now also for prevention and treatment of cancer-associated venous thromboembolism?

Authors:  Ingrid Pabinger; Julia Riedl
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 6.  Anticoagulation for the treatment of venous thromboembolism in patients with brain metastases: a meta-analysis and systematic review.

Authors:  Bradley D Hunter; Tracy Minichiello; Stephen Bent
Journal:  J Thromb Thrombolysis       Date:  2017-10       Impact factor: 2.300

7.  FOTROCAN Delphi consensus statement regarding the prevention and treatment of cancer-associated thrombosis in areas of uncertainty and low quality of evidence.

Authors:  P Jimenez-Fonseca; A Carmona-Bayonas; C Calderon; J Fontcuberta Boj; C Font; R Lecumberri; M Monreal; A J Muñoz Martín; R Otero; A Rubio; P Ruiz-Artacho; C Suarez Fernández; E Colome; P Pérez Segura
Journal:  Clin Transl Oncol       Date:  2017-02-27       Impact factor: 3.405

Review 8.  Initial anticoagulation in patients with pulmonary embolism: thrombolysis, unfractionated heparin, LMWH, fondaparinux, or DOACs?

Authors:  Jenneke Leentjens; Mike Peters; Anne C Esselink; Yvo Smulders; Cornelis Kramers
Journal:  Br J Clin Pharmacol       Date:  2017-07-09       Impact factor: 4.335

Review 9.  Thrombosis in cancer patients: etiology, incidence, and management.

Authors:  Rahul A Sheth; Andrew Niekamp; Keith B Quencer; Fadi Shamoun; Martha-Gracia Knuttinen; Sailendra Naidu; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

10.  Superior vena cava syndrome complicated with acute pulmonary thromboembolism in a patient with lung cancer.

Authors:  Chye-Gen Chin; Jong-Shiuan Yeh; Yung-Kuo Lin; Weng-Chio Tam
Journal:  J Cardiol Cases       Date:  2017-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.